(Q53150011)

11 May 2018

title

Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). (English)

1 reference

11 May 2018

1 reference

cardiovascular disease

1 reference

1 reference

7

Kai-Uwe Eckardt

1 reference

11 May 2018

author name string

Charles A Herzog

1

1 reference

11 May 2018

Richard W Asinger

2

1 reference

11 May 2018

Alan K Berger

3

1 reference

11 May 2018

David M Charytan

4

1 reference

11 May 2018

Javier Díez

5

1 reference

11 May 2018

Robert G Hart

6

1 reference

11 May 2018

Bertram L Kasiske

8

1 reference

11 May 2018

Peter A McCullough

9

1 reference

11 May 2018

Rod S Passman

10

1 reference

11 May 2018

Stephanie S DeLoach

11

1 reference

11 May 2018

Patrick H Pun

12

1 reference

11 May 2018

Eberhard Ritz

13

1 reference

11 May 2018

language of work or name

English

0 references

publication date

13 July 2011

1 reference

11 May 2018

published in

Kidney International

1 reference

11 May 2018

volume

80

1 reference

11 May 2018

issue

6

1 reference

11 May 2018

page(s)

572-586

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1038/ki.2011.223

exact match

0 references

cites work

Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Chronic kidney disease is associated with angiographic coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Acute myocardial infarction and renal dysfunction: a high-risk combination

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Poor long-term survival after acute myocardial infarction among patients on long-term dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

The Framingham predictive instrument in chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Anti-inflammatory agents and antioxidants as a possible "third great wave" in cardiovascular secondary prevention

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Inflammation and cardiovascular events in individuals with and without chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Aldosterone: effects on the kidney and cardiovascular system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Association of activated vitamin D treatment and mortality in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Coronary Risk Assessment and Management Options in Chronic Kidney Disease Patients Prior to Kidney Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomograph

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the Americ

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Evaluation of diabetic patients for renal and pancreas transplantation: noninvasive screening for coronary artery disease using radionuclide methods

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Usefulness of stress echocardiography for risk stratification and prognosis of patients with left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Influence of wall stress and left ventricular geometry on the accuracy of dobutamine stress echocardiography

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

The diagnostic and prognostic value of tissue Doppler imaging during dobutamine stress echocardiography in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Differential symptoms of acute myocardial infarction in patients with kidney disease: a community-wide perspective

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Cardiac troponins in renal insufficiency: review and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Reverse epidemiology in patients with chronic kidney disease who are not yet on dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

"U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Blood pressure and mortality among hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Effect of pravastatin on cardiovascular events in people with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Renal function and outcomes in acute coronary syndrome: impact of clopidogrel

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Rev

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Early angiography in patients with chronic kidney disease: a collaborative systematic review

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommen

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evide

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Risks of coronary artery bypass surgery in dialysis-dependent patients--analysis of the 2001 National Inpatient Sample

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Differential survival after coronary revascularization procedures among patients with renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Comparison of drug-eluting stents and coronary artery bypass grafting for the treatment of multivessel coronary artery disease in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Cardiorenal versus renocardiac syndrome: is there a difference?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Increased prevalence of coronary artery disease, silent myocardial ischemia, complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertrophy, mitral annular calcium, and aortic valve calcium in patients with chronic renal insuffic

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Cardiovascular disease in chronic kidney disease from a cardiologist's perspective

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Arterial structure and function in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Reduced ascending aortic strain and distensibility: earliest manifestations of vascular aging in humans

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Emerging role of the bufadienolides in cardiovascular and kidney diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Congestive heart failure in chronic kidney disease: disease-specific mechanisms of systolic and diastolic heart failure and management

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Haemodialysis-induced myocardial stunning in chronic kidney disease - a new aspect of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Echocardiography in chronic kidney disease: diagnostic and prognostic implications

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Heart failure, chronic kidney disease, and biomarkers--an integrated viewpoint--.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failur

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Serial increased cardiac troponin T predicts mortality in asymptomatic patients treated with chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

ADQI 7: the clinical management of the Cardio-Renal syndromes: work group statements from the 7th ADQI consensus conference

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Analysis of heart morphology and function following erythropoietin treatment of anemic dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Ferric carboxymaltose in patients with heart failure and iron deficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

The importance of dialysate sodium concentration in determining interdialytic weight gains in chronic hemodialysis patients: the PanThames Renal Audit.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Cardiorenal syndrome: new perspectives

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Low glomerular filtration rate and risk of stroke: meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Elevated risk of stroke among patients with end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Stroke in patients on maintenance hemodialysis: a 22-year single-center study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Incidence, etiology, and outcome of stroke in patients on continuous ambulatory peritoneal dialysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Chronic kidney disease and clinical outcome in patients with acute stroke

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Carotid endarterectomy benefits patients with CKD and symptomatic high-grade stenosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Stenting versus endarterectomy for treatment of carotid-artery stenosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Defining the high-risk patient for carotid endarterectomy: an analysis of the prospective National Surgical Quality Improvement Program database

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Chronic renal insufficiency and risk of early mortality in patients undergoing carotid endarterectomy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Epidemiologic features of chronic atrial fibrillation: the Framingham study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Outcome of atrial fibrillation among patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Warfarin in haemodialysis patients with atrial fibrillation: what benefit?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.2011.223

1 reference

7 January 2021

Left atrial appendage occlusion--closure or just the beginning?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Key comorbid conditions that are predictive of survival among hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Peripheral vascular disease and serum phosphorus in hemodialysis: a nested case-control study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Peripheral arterial disease as a predictor of outcome after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Cilostazol improves long-term patency after percutaneous transluminal angioplasty in hemodialysis patients with peripheral artery disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Predictors of poor outcome in female patients undergoing endovascular intervention

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Functional outcome after surgical treatment for intermittent claudication

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Long-term outcomes of revascularization for peripheral vascular disease in end-stage renal disease patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Diabetes is the strongest risk factor for lower-extremity amputation in new hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Impact of renal insufficiency on short-term morbidity and mortality after lower extremity revascularization: data from the Department of Veterans Affairs' National Surgical Quality Improvement Program

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

A decade experience with infrainguinal revascularization in a dialysis-dependent patient population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Preventing amputations among patients with diabetes on dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Can we prevent sudden cardiac death in dialysis patients?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Predictors of survival after cardiac arrest in outpatient hemodialysis clinics

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Cardiac arrest and sudden death in dialysis units

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Clinical findings and outcomes of intra-hemodialysis cardiopulmonary resuscitation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Effect of dialysis dose and membrane flux in maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

The association of sudden cardiac death with inflammation and other traditional risk factors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Kidney dysfunction and sudden cardiac death among women with coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Cystatin C and sudden cardiac death risk in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Firefighting and death from cardiovascular causes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Sudden cardiac death and dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Sudden death in chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Sudden death due to cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Characteristics of sudden death in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Outcome of cardiac arrests attended by emergency medical services staff at community outpatient dialysis centers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Predictors and outcome of cardiopulmonary resuscitation (CPR) calls in a large haemodialysis unit over a seven-year period.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Sudden and cardiac death rates in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Sleep apnea syndrome in chronic renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Digoxin associates with mortality in ESRD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Increased complication rates of cardiac rhythm management devices in ESRD patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.223

7 January 2021

Identifiers

DOI

10.1038/KI.2011.223

1 reference

11 May 2018

1 reference

11 May 2018